Limited Scope of FDA Approval The most significant limitation is the narrow approved indication: FDA approval restricted exclusively to acquired, generalized hypoactive sexual desire disorder in premenopausal women No approved indication for men despite Phase 2 evidence of erectile dysfunction improvement No approval for postmenopausal women No approval for other forms of sexual dysfunction beyond HSDD All use outside this single indication represents off-label prescribing based on limited clinical trial data and physician clinical experience
A 12 to 22 percent increase in natural GLP-1 levels is meaningful from a statistical standpoint
Adipose tissue-derived adiponectin, 179 a type of lipokine that includes palmitoleic acid (C16:1n7), 180 contributes to interorgan communication with tissues such as the liver and muscle, with a potential role in ameliorating insulin resistance and type 2 diabetes in humans
Antioxidant supplements such as glutathione offer generous benefits to detoxification, immune response, and cell functionality
It supports bone integrity, growth hormone regulation, glucose metabolism, and alleviates vasomotor symptoms
